Nécessite une authentification

HEA BeadChip™ technology in immunohematology

À propos de cet article

Citez

Reid ME. Transfusion in the age of molecular diagnostics. Hematology 2009;171–7.10.1182/asheducation-2009.1.171290678420008196Search in Google Scholar

Reid ME, Lomas-Francis C, Olsson L. The blood group antigen. FactsBook. 3rd ed. London: Elsevier, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar

Reid ME, Denomme GA. DNA-based methods in the immunohematology reference laboratory. Transfus Apher Sci 2011;44:65–72.10.1016/j.transci.2010.12.011305826821257350Search in Google Scholar

Denomme GA. Molecular basis of blood group expression. Transfus Apher Sci 2011;44:53–63.10.1016/j.transci.2010.12.01021277830Search in Google Scholar

Denomme GA, Johnson ST, Pietz BC. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci 2011;44:93–9.10.1016/j.transci.2010.12.01221292556Search in Google Scholar

Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45:680–8.10.1111/j.1537-2995.2005.04362.x15847654Search in Google Scholar

Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007;47:736–47.10.1111/j.1537-2995.2007.01178.x17381634Search in Google Scholar

Castilho L. The value of DNA analysis for antigen in the Duffy blood group system. Transfusion 2007;47(1 Suppl):28S–31S.10.1111/j.1537-2995.2007.01307.x17593283Search in Google Scholar

Nataf J, Poupl S, Gien D, et al. The rare Dantu phenotype: serologic aspects and new screening approach through red blood cell (RBC) genotyping. Transfusion 2013;53(2 Suppl):48A.Search in Google Scholar

Crowley JA, Colvin CJ, Horn T, et al. Unexpected HEA BeadChip™ findings point to unusual variant GYPB alleles. Transfusion 2014;54(2 Suppl):46A.Search in Google Scholar

Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.10.1056/NEJM1990060732223012342522Search in Google Scholar

Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusion. Transfusion 2002;42:37–43.10.1046/j.1537-2995.2002.00007.x11896310Search in Google Scholar

Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009;49:453–7.10.1111/j.1537-2995.2008.01980.x19243541Search in Google Scholar

Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–9.10.1046/j.1537-2995.1994.34794330008.x8053036Search in Google Scholar

Vichinsky EP, Luban NLC, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar

LaSalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14-year experience from a single center. Transfusion 2011;51:1732–9.10.1111/j.1537-2995.2010.03045.x21332724Search in Google Scholar

Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang 2014;106:197–208.10.1111/vox.1208624117723Search in Google Scholar

Hillyer CD, Shaz BH, Winkler AM, et al. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008;22:117–32.10.1016/j.tmrv.2007.12.00218353252Search in Google Scholar

Jungbauer C. Routine use of DNA testing for red cell antigens in blood centres. Transfus Apher Sci 2011;45:61–8.10.1016/j.transci.2011.06.00421741314Search in Google Scholar

Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009;97:198–206.10.1111/j.1423-0410.2009.01209.x19548962Search in Google Scholar

Moulds JM. Implementation of HEA at blood centers: prescreening, rare donors, inventory management. In: BeadChip molecular immunohematology. Toward routine donor and patient antigen profiling by DNA analysis. Moulds JM, Ness PM, Sloan SR, eds. Springer, New York, 2011:33–56.Search in Google Scholar

Klapper E. Implementation of HEA BeadChip™ system at medical centers: providing extended matched units and eliminating complex workups for patients. In: BeadChip molecular immunohematology. Toward routine donor and patient antigen profiling by DNA analysis. Moulds JM, Ness PM, Sloan SR, eds. Springer, New York, 2011:57–71.Search in Google Scholar

Sapatnekar S, Figueroa PI. How do we use molecular red blood cell antigen typing to supplement pretransfusion testing? Transfusion 2014;54:1452–8.10.1111/trf.1262324654601Search in Google Scholar

Strauss D, Reid ME. Value of DNA-based assays for donor screening and regulatory issues. Immunohematology 2008;24:175–9.10.21307/immunohematology-2019-295Search in Google Scholar

Shafi H, Abumuhor I, Klapper E. How we incorporate molecular typing of donors and patients into our hospital transfusion service. Transfusion 2014;54:1212–9.10.1111/trf.1258224628032Search in Google Scholar

Badjie KSW, Tauscher C, Van Buskirk C, et al. Red blood cell phenotype matching for various ethnic groups. Immunohematology 2011;27:12–8.10.21307/immunohematology-2019-169Search in Google Scholar

Klapper E, Zhang Y, Figueroa P, et al. Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010;50:536–46.10.1111/j.1537-2995.2009.02462.x19929860Search in Google Scholar

Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381–8.10.1111/j.1537-2995.2011.03288.x21827505Search in Google Scholar

Flickinger C, Meny G, Nance SJ. The ongoing need for rare blood donors. Transfusion 2014;54(2 Suppl):154A.Search in Google Scholar

Remeikiene D, Ugenskiene R, Inciura A, et al. Duffy and Kidd genotyping facilitates pre-transfusion testing in patients undergoing long-term transfusion therapy. Turk J Haematol 2014;31:367–73.10.4274/tjh.2013.0075445405125541653Search in Google Scholar

Bakanay SM, Ozturk A, Ileri T, et al. Blood group genotyping in multi-transfused patients. Transfus Apher Sci 2013;48: 257–61.10.1016/j.transci.2013.01.00923433825Search in Google Scholar

El Kenz H, Efira A, Le PQ, et al. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help? Transl Res 2014;163:36–42.10.1016/j.trsl.2013.09.00724120494Search in Google Scholar

Crews WS, Parsons B, Sutor LJ, et al. Molecular genotyping and modification of pretransfusion testing will decrease cost and turnaround time (TAT) for patients requiring complex antibody workups. Transfusion 2014:54(2 Suppl):153A.Search in Google Scholar

Ribeiro KR, Guarnieri MH, da Costa DC, et al. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009;97:147–52.10.1111/j.1423-0410.2009.01185.x19392786Search in Google Scholar

da Costa DC, Pellegrino JJR, Guelsin GAS, et al. Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients. Rev Bras Hematol Hemoter 2013;35:35–8.10.5581/1516-8484.20130012362163323580882Search in Google Scholar

Flickinger C, Keller MA, Meny G, et al. Providing units for patients with anti-E and antibodies to hrB, hrS or e variants: an update. Transfusion 2014;54(2 Suppl):149A.Search in Google Scholar

Gaspardi AC, Sippert E, Carvalho C, et al. Applying molecular assays to enhanced immunohematology and guide selection of antigen-matched red blood cell components for transfusion. Transfusion 2014;54(2 Suppl):154A.Search in Google Scholar

Revelli N, Villa MA, Paccapelo C, et al. The Lombardy Rare Donor Programme. Blood Transfus 2014;12(Suppl 1): S249–55.Search in Google Scholar

Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/ KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008;112:2081–8.10.1182/blood-2008-03-14567218487511Search in Google Scholar

eISSN:
1930-3955
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, Laboratory Medicine